Sri Spr Biologics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 27.53%
(FY 2023)
- Profit 23.84%
(FY 2023)
- Ebitda 98.96%
(FY 2023)
- Net Worth 1380.47%
(FY 2023)
- Total Assets 9.45%
(FY 2023)
About Sri Spr Biologics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chinnasaida Kamireddy, Srinarayana Medam, and Chaitanya Reddy serve as directors at the Company.
- CIN/LLPIN
U24233AP2015PTC096307
- Company No.
096307
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Spr Biologics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chinnasaida Kamireddy  | Director | 12-Mar-2015 | Current |
| Srinarayana Medam | Director | 12-Mar-2015 | Current |
| Chaitanya Reddy | Director | 12-Mar-2015 | Current |
Financial Performance of Sri Spr Biologics.
Sri Spr Biologics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.53% increase. The company also saw a substantial improvement in profitability, with a 23.84% increase in profit. The company's net worth Soared by an impressive increase of 1380.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Spr Biologics?
Unlock access to Sri Spr Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sri Spr Global Consulting Services Private LimitedActive 8 years 2 months
Chaitanya Reddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Spr Biologics?
Unlock and access historical data on people associated with Sri Spr Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Spr Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Spr Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
